Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
PCRX Pacira BioSciences
- 18.580
- -0.100-0.54%
Close Jan 8 16:00 ET
- 18.580
- 0.0000.00%
Post 16:20 ET
857.90MMarket Cap-9.38P/E (TTM)
18.840High18.180Low394.41KVolume18.550Open18.680Pre Close7.34MTurnover0.86%Turnover Ratio20.88P/E (Static)46.17MShares34.01052wk High1.14P/B848.63MFloat Cap11.16452wk Low--Dividend TTM45.67MShs Float121.950Historical High--Div YieldTTM3.53%Amplitude6.160Historical Low18.617Avg Price1Lot Size
About Pacira BioSciences Company
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.
Company Profile
SymbolPCRX
Company NamePacira BioSciences
Listing DateFeb 3, 2011
Issue Price7.00
Founded2006
CEOMr. Frank D. Lee
MarketNASDAQ
Employees712
Fiscal Year Ends12-31
Address5401 West Kennedy Boulevard,Suite 890
CityTampa
ProvinceFlorida
CountryUnited States of America
Zip Code33609
Phone1-813-553-6680
Websitehttp://www.pacira.com
Company Executives
- Name
- Position
- Salary
- Frank D. Lee
- Director and Chief Executive Officer
- --
- Shawn M. Cross
- Chief Financial Officer
- --
- Daryl Gaugler
- Chief Operating Officer
- 1.53M
- Jonathan Slonin
- Chief Medical Officer
- 1.59M
- Kristen Marie Williams
- Chief Administrative Officer and Secretary
- 1.60M
- Lauren Riker
- Principal Accounting Officer and Senior Vice President, Finance
- --
- Paul J. Hastings
- Chairman of the Board
- 390.51K
- Michael J. Yang
- Independent Director
- 427.16K
- Governor Christopher J. Christie
- Independent Director
- 325.01K
- Alethia Young
- Independent Director
- 427.86K
- Abraham N. Ceesay, M.B.A.
- Independent Director
- 427.16K
- Dr. Mark I. Froin, M.D.
- Independent Director
- 349.01K
- Dr. Mark A. Kronenfeld, M.D.
- Independent Director
- 373.01K
- Laura A. Brege
- Independent Director
- 364.01K
- Dr. Marcelo Bigal, M.D.,PhD
- Independent Director
- 426.45K
- Dr. Andreas Wicki, PhD
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.